Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
Use this CHRS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CHRS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CHRS SEC filings page. Lician reads the product cache first so this HTML stays unique to Coherus BioSciences Inc even when a live quote feed is slow.
Latest cached year on this hub. Full CHRS income, balance, and cash tables.